The Lowering of Vascular Atherosclerotic Risk (LOVAR) program: an approach to modifying cerebral, cardiac, and...

Area of Science:

• Cardiology
• Vascular Medicine
• Preventive Cardiology

Background:

• Cardiovascular diseases (CVD) cause over 1 million deaths annually in the US.
• Translating clinical trial findings into practice for CVD risk reduction remains a challenge.
• High-risk populations require effective strategies for managing modifiable risk factors.

Purpose of the Study:

• To evaluate the feasibility of a high-intensity, multidisciplinary risk factor reduction program (LOVAR).
• To assess the impact of the LOVAR program on patients with symptomatic CVD and multiple risk factors.
• To compare outcomes and quality of life between an intervention group and a standard care control group.

Main Methods:

• A 5-year observational study involving 271 patients in the intervention group and 242 in the control group.
• Participants had symptomatic cerebral, cardiac, or peripheral vascular disease and at least two modifiable risk factors.
• Outcomes included primary and secondary end points, quality of life, patient retention, and satisfaction.

Main Results:

• The intervention group showed significant improvements in multiple risk factors at 3 years.
• No significant improvements were observed in the control group.
• Patient retention was high (95% at 3 years), with high overall satisfaction rates.

Conclusions:

• The LOVAR program demonstrates feasibility and effectiveness in reducing vascular disease risk factors.
• A high-intensity, multidisciplinary approach is beneficial for motivated, high-risk populations.
• The LOVAR program's success suggests generalizability to similar patient cohorts.